Biogen Inc. - Company & Market Research Reports

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.


Remicade Biosimilar Market: By Type, By Technology, By Service, By Application, By Region - Forecast 2016-2021 - Product Thumbnail Image

Remicade Biosimilar Market: By Type, By Technology, By Service, By Application, By Region - Forecast 2016-2021

  • Report
  • 146 Pages
From
Monoclonal Antibodies Market: By Application [Oncology, Autoimmune and inflammatory diseases, Respiratory diseases and Ophthalmology] & By Geography - Forecast 2016-2021 - Product Thumbnail Image

Monoclonal Antibodies Market: By Application [Oncology, Autoimmune and inflammatory diseases, Respiratory diseases and Ophthalmology] & By Geography - Forecast 2016-2021

  • Report
  • 135 Pages
From
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 344 Pages
From
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 2500 Pages
From
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 - Product Thumbnail Image

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

  • Report
  • 1600 Pages
From
Global Scleroderma Treatment Market 2017-2021 - Product Thumbnail Image

Global Scleroderma Treatment Market 2017-2021

  • Report
  • 83 Pages
From
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 - Product Thumbnail Image

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

  • Report
  • 1000 Pages
From
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 - Product Thumbnail Image

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018

  • Report
  • 457 Pages
From
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018 - Product Thumbnail Image

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018

  • Report
  • 319 Pages
From
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 - Product Thumbnail Image

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018

  • Report
  • 950 Pages
From
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 2000 Pages
From
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 - Product Thumbnail Image

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018

  • Report
  • 1000 Pages
From
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential - Product Thumbnail Image

Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential

  • Report
  • 199 Pages
From
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis - Product Thumbnail Image

The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis

  • Report
  • 104 Pages
From
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 - Product Thumbnail Image

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018

  • Report
  • 1500 Pages
From
Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 - Product Thumbnail Image

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

  • Report
  • 1000 Pages
From
Global Non-Invasive Prenatal Testing and Newborn Screening Market, 2017-2027 - Product Thumbnail Image

Global Non-Invasive Prenatal Testing and Newborn Screening Market, 2017-2027

  • Report
  • 425 Pages
From
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets - Product Thumbnail Image

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

  • Report
  • 144 Pages
From
United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 980 Pages
From
Rare Hemophilia Factors Market Size, Share & Trends Analysis Report By Type, By Treatment (Fresh Frozen Plasma, Factor Concentrates, Cryoprecipitate), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

Rare Hemophilia Factors Market Size, Share & Trends Analysis Report By Type, By Treatment (Fresh Frozen Plasma, Factor Concentrates, Cryoprecipitate), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025

  • Report
  • 100 Pages
From
Loading Indicator
adroll